GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Clinical trials for GERD (GASTROESOPHAGEAL REFLUX DISEASE) explained in plain language.
Never miss a new study
Get alerted when new GERD (GASTROESOPHAGEAL REFLUX DISEASE) trials appear
Sign up with your email to follow new studies for GERD (GASTROESOPHAGEAL REFLUX DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Fat cells injected into esophagus could tame reflux without surgery
Disease control Not yet recruitingThis pilot study tests whether injecting a patient's own fat-derived cells into the lower esophagus is safe and feasible for treating GERD that doesn't respond well to medication. Fifteen adults with chronic acid reflux will undergo a minimally invasive endoscopic procedure. The …
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
Smarter surgery may cut reflux after achalasia procedure
Disease control Not yet recruitingThis study compares two versions of a minimally invasive procedure called POEM for treating achalasia, a swallowing disorder. The standard POEM often causes severe heartburn afterward. The new version, Sling-Fiber Preserving POEM, aims to reduce that risk by leaving certain stoma…
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Could a simple gel soothe heartburn without drugs? new trial aims to find out
Symptom relief Not yet recruitingThis study tests a new medical device that forms a protective barrier in the esophagus to reduce heartburn and other GERD symptoms. Fifty adults with non-erosive GERD will take the device or a placebo four times daily for two weeks, then switch. The goal is to see if it relieves …
Matched conditions: GERD (GASTROESOPHAGEAL REFLUX DISEASE)
Phase: NA • Sponsor: Cellmedis • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC